Results For "DBT-BRIC"

No record found.

Upcoming E-conference

July 17, 2026 Biosimilars & Biologics: The Next Growth Frontiers for Indian Pharma

Latest Stories

IIT Hyderabad partners with Silicon Labs to develop Made-in-India smart medical devices

Voyageur taps Fluor to fast-track major iodine and contrast drug manufacturing push

GE HealthCare unveils Allia Upgrade pathways to modernise legacy interventional imaging systems

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Interviews

Peptides are next frontline therapeutics led by GLP-1: Dr. Vandana Singh, Head - API Regulatory Sciences, Biocon Limited

Peptides are next frontline therapeutics led by GLP-1: Dr. Vandana Singh, Head - API Regulatory Sciences, Biocon Limited

Rising pharma demand driving our India market strategy: Sanjeev Kumar Khandelwal, Head of Division, Characterization Division, Anton Paar India

Rising pharma demand driving our India market strategy: Sanjeev Kumar Khandelwal, Head of Division, Characterization Division, Anton Paar India

India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India

India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India

Sanjay Vyas President and Managing Director, Parexel India And Global SBU Head- Safety services & Logistics, Parexel International

Packaging